Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
Clinical trial NCT05050149 · COMPLETED
Trial details
- NCT number
- NCT05050149
- Sponsor
- Palvella Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-13
- Primary completion
- 2022-11-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.